Screener
Eton Pharmaceuticals, Inc. ETON Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 67,095 | 65,960 |
| Commitments and contingencies (Note 13) | ||
| Stockholders’ equity | ||
| Common stock, $0.001 par value; 50,000,000 shares authorized; 27,359,791 and 27,047,061 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 27 | 27 |
| Additional paid-in capital | 141,528 | 138,621 |
| Accumulated deficit | (110,940) | (112,494) |
| Total stockholders’ equity | 30,615 | 26,154 |
| Total liabilities and stockholders’ equity | $97,710 | $92,114 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s total liabilities & equity?
- Eton Pharmaceuticals, Inc. (ETON) reported total liabilities & equity of $97.71M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s total liabilities & equity changed year-over-year?
- Eton Pharmaceuticals, Inc.'s total liabilities & equity increased by 16.3% year-over-year, from $84.03M to $97.71M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s total liabilities & equity has grown at a 28.5% compound annual growth rate (CAGR), from $26.32M to $92.11M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Eton Pharmaceuticals, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude